
Varex Imaging Corporation VREX
$ 12.07
0.0%
Quarterly report 2025-Q4
added 02-10-2026
Varex Imaging Corporation Accounts Payables 2011-2026 | VREX
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Varex Imaging Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.9 M | 59.1 M | 64.7 M | 78.2 M | 58.8 M | 72.9 M | 58.2 M | 66.3 M | 58.9 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 78.2 M | 58.2 M | 65.2 M |
Quarterly Accounts Payables Varex Imaging Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.9 M | 69.9 M | 70.7 M | 70.8 M | 65.6 M | 59.1 M | 69.6 M | 69.4 M | 73.7 M | 64.7 M | 74.6 M | 74.2 M | 86.2 M | 78.2 M | - | 78.8 M | 71.6 M | 58.8 M | 66.2 M | 58.8 M | 73.2 M | 72.9 M | 72.9 M | 72.9 M | - | 58.2 M | 58.2 M | 58.2 M | 65.7 M | 66.3 M | 66.3 M | 66.3 M | 58.3 M | 58.9 M | 58.9 M | 58.9 M | 39.7 M | 41.9 M | 41.9 M | 41.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 86.2 M | 39.7 M | 65 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.28 | - | $ 123 M | ||
|
Electromed
ELMD
|
2.67 M | $ 25.74 | - | $ 218 M | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 90.74 | - | $ 12.3 B | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 2.08 | - | $ 1.26 M | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 13.38 | - | $ 1.81 B | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
Pulmonx Corporation
LUNG
|
3.9 M | $ 1.23 | - | $ 50 M | ||
|
Orthofix Medical
OFIX
|
58.4 M | $ 11.91 | - | $ 472 M | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
Insulet Corporation
PODD
|
75 M | $ 182.87 | - | $ 12.9 B | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.6 | -1.96 % | $ 37.3 M | ||
|
Sintx Technologies
SINT
|
382 K | $ 2.15 | - | $ 5.96 M | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 11.08 | - | $ 314 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Stryker Corporation
SYK
|
1.8 B | $ 321.43 | -0.02 % | $ 123 B | ||
|
Tactile Systems Technology
TCMD
|
4.97 M | $ 23.57 | - | $ 539 M | ||
|
TELA Bio
TELA
|
2.31 M | $ 0.78 | - | $ 36.6 M | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | ||
|
TransMedics Group
TMDX
|
10.4 M | $ 101.26 | - | $ 3.44 B | ||
|
Tandem Diabetes Care
TNDM
|
47.1 M | $ 18.63 | - | $ 1.27 B | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 5.16 | - | $ 1.09 B | ||
|
Vivos Therapeutics
VVOS
|
1.68 M | $ 0.85 | - | $ 8.73 M | ||
|
Beyond Air
XAIR
|
1.95 M | $ 0.51 | - | $ 34.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
18.8 M | $ 15.14 | - | $ 355 M | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 10.55 | - | $ 378 M | ||
|
Xtant Medical Holdings
XTNT
|
3.84 M | $ 0.55 | -1.78 % | $ 76.7 M | ||
|
Zimmer Biomet Holdings
ZBH
|
195 M | $ 82.8 | - | $ 16.8 B | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.04 | - | $ 17.6 M | ||
|
CONMED Corporation
CNMD
|
93.6 M | $ 36.79 | - | $ 1.14 B |